If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.



Company Spending On U.S. R&D Rises

by Andrea Widener
August 31, 2015 | A version of this story appeared in Volume 93, Issue 34

CORRECTION: This story was updated on Oct. 8, 2015, to correct the chemical manufacturing R&D spending figures to billions of dollars.

Annual business spending on research and development in the U.S. rose almost 7% in 2013 to $323 billion, a report from the National Science Foundation shows. The biggest increase was in research supported by companies themselves, with spending up 7.1% to $265 billion from 2012 to 2013, the most recent year for which data are available. Funding from external sources was also up, rising 4.8% to $58 billion. At the same time, the federal government’s support for research at companies fell 4.1% to $29 billion. The chemical manufacturing sector’s R&D reflected a similar trend to industry overall, with a 7.7% increase in U.S.-based R&D to $62 billion in 2013. Chemical companies paid for most of that research with $54 billion in internal R&D spending, up 6.7%. Foreign companies increased payments for chemical research at U.S. companies, up 21.5% to $5.6 billion. Meanwhile, federal spending on chemical industry R&D was down 3.5%. Pharmaceutical production, a subset of chemical manufacturing, had among the highest R&D spending as a percentage of sales at 10.3%, compared with 4.5% for the sector overall.


This article has been sent to the following recipient:

Chemistry matters. Join us to get the news you need.